Identification of binding sites of non-I-helix water molecules in mammalian cytochromes P450

Drug Metabolism and Disposition

Volumn 34, Issue 12, 2006, Pages 1954-1957

  Locuson, Charles W ^a,b   Tracy, Timothy S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; THREONINE; WATER;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; DENSITY; ENZYME ACTIVE SITE; ENZYME MECHANISM; HYDROGEN BOND; HYDROPHILICITY; PRIORITY JOURNAL; PROTEIN DATA BANK;

ANIMALS; BACTERIA; BINDING SITES; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; PROTEIN CONFORMATION; RABBITS; WATER;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 33751544804     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.106.011890     Document Type: Article

References (33)

1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, and Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28:235-242.
2. Blobaum AL (2006) Mechanism-based inactivation and reversibility: is there a new trend in the inactivation of cytochrome P450 enzymes? Drug Metab Dispos 34:1-7.
3. Bottoms C, White T, and Tanner J (2006) Exploring structurally conserved solvent sites in protein families. Proteins 64:404-421.
4. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, et al. (1998) Crystallography & NMR System: a new software suite for macromolecular structure determination. Acta Crystallogr Sec D 54:905-921.
5. Clark JP, Miles CS, Mowat CG, Walkinshaw MD, Reid GA, Daff SN, and Chapman SK (2006) The role of Thr268 and Phe393 in cytochrome P450 BM3. J Inorg Biochem 100:1075-1090.
6. Denisov IG, Makris TM, Sligar SG, and Schlichting I (2005) Structure and chemistry of cytochrome P450. Chem Rev 105:2253-2277.
7. Dickmann LJ, Rettie AE, Kneller MB, Kim RB, Wood AJ, Stein CM, Wilkinson GR, and Schwarz UI (2001) Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans. Mol Pharmacol 60:382-387.
8. Gerber NC and Sligar SG (1994) A role for Asp-251 in cytochrome P-450cam oxygen activation. J Biol Chem 269:4260-4266.
9. Honma W, Li W, Liu H, Scott EE, and Halpert JR (2005) Functional role of residues in the helix B′ region of cytochrome P450 2B1. Arch Biochem Biophys 435:157-165.
10. Imai M, Shimada H, Watanabe Y, Matsushima-Hibiya Y, Makino R, Koga H, Horiuchi T, and Ishimura Y (1989) Uncoupling of the cytochrome P-450cam monooxygenase reaction by a single mutation, threonine-252 to alanine or valine: possible role of the hydroxy amino acid in oxygen activation. Proc Natl Acad Sci USA 86:7823-7827.
11. Johnson EF and Stout CD (2005) Structural diversity of human xenobiotic-metabolizing cytochrome P450 monooxygenases. Biochem Biophys Res Commun 338:331-336.
12. Li W, Liu H, Scott EE, Grater F, Halpert JR, Luo X, Shen J, and Jiang H (2005) Possible pathway(s) of testosterone egress from the active site of cytochrome P450 2B1: a steered molecular dynamics simulation. Drug Metab Dispos 33:910-919.
13. Nagano S and Poulos TL (2005) Crystallographic study on the dioxygen complex of wild-type and mutant cytochrome P450cam. Implications for the dioxygen activation mechanism. J Biol Chem 280:31659-31663.
14. Nelson DR and Strobel HW (1989) Secondary structure prediction of 52 membrane-bound cytochromes P450 shows a strong structural similarity to P450cam. Biochemistry 28:656-660.
15. Oprea TI, Hummer G, and Garcia AE (1997) Identification of a functional water channel in cytochrome P450 enzymes. Proc Natl Acad Sci USA 94:2133-2138.
16. Ost T, Clark J, Miles C, Walkinshaw M, Reid G, Chapman S, Daff S, and Mowat C (2003) F393A mutant heme domain of flavocytochrome P450 BM3. J Am Chem Soc 125:15010-15020.
17. Poulos TL, Finzel BC, Gunsalus IC, Wagner GC, and Kraut J (1985) The 2.6-A crystal structure of Pseudomonas putida cytochrome P-450. J Biol Chem 260:16122-16130.
18. Raag R, Martinis SA, Sligar SG, and Poulos TL (1991) Crystal structure of the cytochrome P-450CAM active site mutant Thr252Ala. Biochemistry 30:11420-11429.
19. Rowland P, Blaney FE, Smyth MG, Jones JJ, Leydon VR, Oxbrow AK, Lewis CJ, Tennant MG, Modi S, Eggleston DS, et al. (2006) Crystal structure of human cytochrome P450 2D6. J Biol Chem 281:7614-7622.
20. Schleinkofer K, Sudarko, Winn PJ, Ludemann SK, and Wade RC (2005) Do mammalian cytochrome P450s show multiple ligand access pathways and ligand channelling? EMBO Rep 6:584-589.
21. Schlichting I, Berendzen J, Chu K, Stock AM, Maves SA, Benson DE, Sweet RM, Ringe D, Petsko GA, and Sligar SG (2000) The catalytic pathway of cytochrome P450cam at atomic resolution. Science (Wash DC) 287:1615-1622.
22. Schoch GA, Yano JK, Wester MR, Griffin KJ, Stout CD, and Johnson EF (2004) Structure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding site. J Biol Chem 279:9497-9503.
23. Scott EE, He YA, Wester MR, White MA, Chin CC, Halpert JR, Johnson EF, and Stout CD (2003) An open conformation of mammalian cytochrome P450 2B4 at 1.6-A resolution. Proc Natl Acad Sci USA 100:13196-13201.
24. Scott EE, White MA, He YA, Johnson EF, Stout CD, and Halpert JR (2004) Structure of mammalian cytochrome P450 2B4 complexed with 4-(4-chlorophenyl) imidazole at 1.9-A resolution: insight into the range of P450 conformations and the coordination of redox partner binding. J Biol Chem 279:27294-27301.
25. Vaz AD (2001) Multiple oxidants in cytochrome P450 catalyzed reactions: implications for drug metabolism. Curr Drug Metab 2:1-16.
26. Wester MR, Johnson EF, Marques-Soares C, Dansette PM, Mansuy D, and Stout CD (2003a) Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3 A resolution: evidence for multiple substrate binding modes. Biochemistry 42:6370-6379.
27. Wester MR, Johnson EF, Marques-Soares C, Dijols S, Dansette PM, Mansuy D, and Stout CD (2003b) Structure of mammalian cytochrome P450 2C5 complexed with diclofenac at 2.1 A resolution: evidence for an induced fit model of substrate binding. Biochemistry 42:9335-9345.
28. Wester MR, Yano JK, Schoch GA, Yang C, Griffin KJ, Stout CD, and Johnson EF (2004) The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-A resolution. J Biol Chem 279:35630-35637.
29. Williams PA, Cosme J, Vinkovic DM, Ward A, Angove HC, Day PJ, Vonrhein C, Tickle IJ, and Jhoti H (2004) Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone. Science (Wash DC) 305:683-686.
30. Williams PA, Cosme J, Ward A, Angove HC, Matak VD, and Jhoti H (2003) Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature (Lond) 424:464-468.
31. Yano JK, Hsu MH, Griffin KJ, Stout CD, and Johnson EF (2005) Structures of human microsomal cytochrome P450 2A6 complexed With coumarin and methoxsalen. Nat Struct Mol Biol 12:822-823.
32. Yano JK, Wester MR, Schoch GA, Griffin KJ, Stout CD, and Johnson EF (2004) The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution. J Biol Chem 279:38091-38094.
33. Zhao Y, White MA, Muralidhara BK, Sun L, Halpert JR, and Stout CD (2006) Structure of microsomal cytochrome P450 2B4 complexed with the antifungal drug bifonazole: insight into P450 conformational plasticity and membrane interaction. J Biol Chem 281:5973-5981.